Vendor, South San Francisco, CA
Iggenix, Inc.
UEI HBP9HFYHB3Q4, CAGE 8KPW3
1 award and $100,000 obligated between September 4, 2024 and September 23, 2025, 0% under full and open competition, against 1.0 offers on average where reported. 2 of the awards trace back to a SAM.gov solicitation on this site.
Industries
NAICS on the awards, by dollars.
| Biological Product (except Diagnostic) ManufacturingNAICS 325414 | $100,000 |
How it wins
Awards by competition, set-aside and type.
| Competed Under SAP | 1 |
| Purchase Order | 1 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Fel d 1-specific capture and biotin-labeled detection monoclonal antibodies suitable for use in Enzyme Linked Immunosorbent Assay (ELISA/ImmunoEnzymetric Assay (IEMA)
Food and Drug Administration, FDA Center for Biologics Evaluation and Research
Combined synopsis and solicitationNAICS 325414Silver Spring, MDFDARFQ125149Awarded to Iggenix, Inc.
Posted Aug 28, 20242 publications
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75F40124P00438Purchase Order, September 4, 2024, Competed Under SAP, 1 offersSolicitation | FDA Office of Acq Grant SVCSFood and Drug Administration | Fel D 1-Specific Human Ige Class Switched to Ige Monoclonal AntibodiesNAICS 325414, PSC 6515 | $100,000 |
- Places of performance
- California
- Product and service codes
- 6515 Medical and Surgical Instruments, Equipment, and Supplies
- Transactions
- 2 across 1 awards